scispace - formally typeset
T

Tadigoppula Narender

Researcher at Central Drug Research Institute

Publications -  124
Citations -  2512

Tadigoppula Narender is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Insulin resistance & GLUT4. The author has an hindex of 25, co-authored 117 publications receiving 2147 citations. Previous affiliations of Tadigoppula Narender include Scripps Research Institute & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent

TL;DR: From the seeds of T. foenum-graecum an unusual amino acid, 4-hydroxyisoleucine 5, has been isolated, which significantly decreased the plasma triglyceride levels, accompanied by an increase in HDL-C/TC ratio in the dyslipidemic hamster model.
Journal ArticleDOI

A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate

TL;DR: In this paper, the synthesis of substituted acetophenones (2a-12a) with various aromatic aldehydes (1b-7b) in the presence of BF3-Et2O at room temperature gave chalcones in 75% yield.
Journal ArticleDOI

Antihyperglycemic and antidyslipidemic agent from Aegle marmelos

TL;DR: The reasonable mapping of compound 2 to validated pharmacophoric hypothesis and 3D QSAR model with an estimated activity suggest that the compound 2 might be a beta(3)-AR agonist.
Journal ArticleDOI

A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydrochalcones and their in vitro antileishmanial activity

TL;DR: The strategy to conveniently synthesize naturally occurring chromeno dihydrochalcones by biogenetic type pyridine or Amberlyst-15 catalyzed chromenylation of dihydropyranes and in vitro antileishmanial activity of chromenoDihydro Chalcones and their intermediates is reported.
Journal ArticleDOI

Prenylated chalcones isolated from Crotalaria genus inhibits in vitro growth of the human malaria parasite Plasmodium falciparum.

TL;DR: In vitro antimalarial activity of crotaorixin as well as few prenylated chalcones isolated from C. medicagenia and C. ramosissima were evaluated at three concentrations against Plasmodium falciparum (Strain NF-54).